Oncocyte (NASDAQ:IMDX) is pushing for FDA marketing authorization of its GraftAssureDx kidney-transplant rejection test by the end of 2024, as the company ramps up commercial preparation and streamlines operational spending…
HealthCare Global Enterprises Ltd (NSE:HCG) reported a robust start to fiscal year 2027, outlining a clear path toward significant EBITDA margin expansion and sustained revenue growth during its Q1 earnings…
The Canadian government is launching a $100 million financial support program to subsidize the interprovincial transport of domestic steel, Transport Minister Steven MacKinnon announced on Monday, Aug. 10, in Hamilton,…
Paycom Software (NYSE:PAYC) surpassed second-quarter expectations, reporting a 10% year-over-year revenue increase to $531 million, fueled by surging demand for its automation tools and improved operational efficiency. Financial Performance and…
Shares of travel technology leader Sabre (NASDAQ:SABR) dropped 7.8% this afternoon as investors reacted to a mixed second-quarter earnings report, prioritizing a wider-than-expected adjusted loss over the company’s revenue beat…
Silicon Valley’s trillion-dollar push into artificial intelligence risks stalling because corporate leaders are ignoring the “Jersey Pump Principle”—the historical reality that human resistance can freeze even the most advanced technology…
fiado6289@gmail.com